We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$10.6B
AUM Growth
+$4.32B
Cap. Flow
+$4.15B
Cap. Flow %
39.25%
Top 10 Hldgs %
26.92%
Holding
1,909
New
683
Increased
298
Reduced
275
Closed
491

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Consumer Discretionary 5.98%
3 Communication Services 3.46%
4 Healthcare 1.95%
5 Financials 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESTC icon
376
CALL
Elastic
ESTC
$7.15B
$4.95M 0.05%
50,000
RARE icon
377
Ultragenyx Pharmaceutical
RARE
$2.46B
$4.95M 0.05%
117,571
+108,971
+1,267% +$5.41M
GVA icon
378
CALL
Granite Construction
GVA
$5.43B
$4.91M 0.05%
+56,000
New +$5.05M
PCVX icon
379
PUT
Vaxcyte
PCVX
$7.73B
$4.91M 0.05%
60,000
+16,000
+36% +$1.59M
VEL icon
380
CALL
Velocity Financial
VEL
$692M
$4.89M 0.05%
+250,000
New +$4.97M
VEL icon
381
PUT
Velocity Financial
VEL
$692M
$4.89M 0.05%
+250,000
New +$4.97M
BMBL icon
382
PUT
Bumble
BMBL
$403M
$4.88M 0.05%
+600,000
New +$4.63M
AGIO icon
383
PUT
Agios Pharmaceuticals
AGIO
$1.82B
$4.85M 0.05%
147,500
-152,500
-51% -$7.16M
DOCS icon
384
CALL
Doximity
DOCS
$3.89B
$4.81M 0.05%
+90,000
New +$4.41M
SNDX icon
385
PUT
Syndax Pharmaceuticals
SNDX
$1.7B
$4.75M 0.04%
359,300
+97,600
+37% +$1.67M
ALNY icon
386
CALL
Alnylam Pharmaceuticals
ALNY
$29.5B
$4.71M 0.04%
+20,000
New +$5.26M
ALNY icon
387
PUT
Alnylam Pharmaceuticals
ALNY
$29.5B
$4.71M 0.04%
20,000
-4,900
-20% -$1.29M
TGTX icon
388
PUT
TG Therapeutics
TGTX
$7.07B
$4.69M 0.04%
155,700
+125,700
+419% +$3.61M
CHKP icon
389
CALL
Check Point Software Technologies
CHKP
$12.6B
$4.67M 0.04%
25,000
HOOD icon
390
CALL
Robinhood
HOOD
$81.2B
$4.66M 0.04%
+125,000
New +$4.04M
LYB icon
391
CALL
LyondellBasell Industries
LYB
$19.6B
$4.64M 0.04%
+62,500
New +$5.26M
BHC icon
392
CALL
Bausch Health
BHC
$2.62B
$4.57M 0.04%
567,400
+413,700
+269% +$3.41M
VITL icon
393
CALL
Vital Farms
VITL
$548M
$4.56M 0.04%
+121,000
New +$4.3M
PEG icon
394
Public Service Enterprise Group
PEG
$38.2B
$4.55M 0.04%
53,824
-23,576
-30% -$2.09M
AUPH icon
395
PUT
Aurinia Pharmaceuticals
AUPH
$1.87B
$4.53M 0.04%
504,300
+380,000
+306% +$3.1M
CBRE icon
396
CALL
CBRE Group
CBRE
$43B
$4.49M 0.04%
34,200
CVS icon
397
PUT
CVS Health
CVS
$134B
$4.49M 0.04%
+100,000
New +$5.61M
SGML icon
398
PUT
Sigma Lithium
SGML
$1.17B
$4.49M 0.04%
400,000
SMAR
399
CALL
DELISTED
Smartsheet Inc.
SMAR
$4.48M 0.04%
80,000
-102,700
-56% -$5.75M
CELH icon
400
PUT
Celsius Holdings
CELH
$7.22B
$4.48M 0.04%
170,000
-60,000
-26% -$1.78M

Similar funds

Caption Management's Q4 2024 Portfolio in Review

As of Q4 2024, Caption Management held 1,909 positions worth $10.6B, up 69% from $6.27B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Caption Management deployed $4.15B of net new capital in Q4 2024, opening 683 new positions and adding to 298 existing holdings. Its largest new stake was NVIDIA: 4,060,000 shares worth $545M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P Regional Banking ETF, an estimated $63.1M trimmed.

  • Caption Management's largest Q4 2024 buy was NVIDIA: 4,060,000 shares worth $545M.
  • Caption Management added most to Alphabet (Google) Class C in Q4 2024, an estimated $121M increase.
  • Caption Management's biggest Q4 2024 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $63.1M.
  • Caption Management fully exited Broadcom in Q4 2024, selling an estimated $20.5M.
  • Caption Management's ten largest holdings make up 27% of its $10.6B portfolio in Q4 2024.
  • Caption Management opened 683 new positions and closed 491 in Q4 2024.
  • Caption Management's portfolio value rose 69% quarter-over-quarter to $10.6B.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.